Opioid use disorder webinar examines issue in relation to COVID-19

The Jan. 13 webinar will explore current epidemiology, new legislation and innovative resources as well as clinical responses to substance use disorder and overdoses, including various buprenorphine resources. The session will also highlight New York MATTERS' expansion and updates.